• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

News & Events

  • Print
  • Share
  • E-mail

Public Calendar: May 2-6, 2011

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

May 2-6, 2011
FDA Official and TitleDateLocationOther FDA ParticipantsNon-FDA ParticipantsSubject
Margaret A. Hamburg, M.D., Commissioner of Food and Drugs5/2/11Silver Spring, MDJohn M. Taylor, Ralph Tyler, Michael R. Taylor, Dara Corrigan, Donald Kraemer, Jeff Farrar, Michelle DiFilippoJohn Bryant, Timothy Goaley, Gary Pilnick (Kellogg Company); Joseph Levitt (Hogan Lovells US LLP)Food Safety
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs5/2/11Silver Spring, MDDara Corrigan, Kathy Martin-Weiss, Carolyn BeckerGordon Snow, Zachary Miller, Christopher Graham, Paul Tiao (FBI)Collaboration
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs5/2/11Silver Spring, MDKaren Midthun, Mark Malarkey, Eric Blumberg, Howard Sklamberg, Brenda Holman, Evelyn Bonnin, Richard Davey, Peter LurieShaun Gilmore and several representatives from American Red CrossAmerican Red Cross
John M. Taylor, III, J.D., Acting Principal Deputy Commissioner of Food and Drugs5/2/11Washington, DCJeanne Ireland, Deborah AutorSenator Bennet, Jonathan Davidson (Chief of Staff), Rohini Ravindran (Health Policy Advisor)Drug Safety
Dara A. Corrigan, Associate Commissioner for Regulatory Affairs5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Curtis L. Coy, Deputy Commissioner for Administration5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Lawrence Deyton, M.S.P.H., M.D., Director, Center for Tobacco Products5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
David Dorsey, J.D., Acting Deputy Commissioner for Policy, Planning, and Budget5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Bernadette Dunham, D.V.M., Ph.D., Director, Center for Veterinary Medicine5/2/11- 5/6/11N/AvN/ANo Significant Meetings
Jesse Goodman, M.D., M.P.H., Chief Scientist and Deputy Commissioner for Science and Public Health5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Murray M. Lumpkin, M.D., Deputy Commissioner for International Programs5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Karen Midthun, M.D., Director, Center for Biologics Evaluation and Research5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Meghan Scott, Acting Associate Commissioner for External Affairs5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Michael R. Taylor, J.D., Deputy Commissioner for Foods, Office of Foods5/2/11Silver Spring, MDDon Kraemer, Jeanne Ireland, Mitch Cheeseman, Pat Hansen, Phil Broadbent, Caitlin BoonFran Drescher, Laurie Meadoff, Jordan Brown, Maryam Razmandi (Cancer Schmancer Movement); Claire Kraft (Public Service Network); Jason Rano (Environmental Working Group)Disease Prevention and Consumer Protection from Toxic Chemicals
Ralph Tyler, J.D., Chief Counsel5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Roberta Wagner, Acting Director, Center for Food Safety and Applied Nutrition5/4/11College Park, MDNancy Yanish, Crysta Rivers, Antonia Mattia, Jessica Leighton, Barbara Schneeman, Ken Smith, Paula Trumbo, Claudine KavanaughLori Roman, Mort Satin (Salt Institute)Salt, Diet and Health
Jill Hartzler Warner, J.D., Acting Associate Commissioner for Special Medical Programs5/2/11- 5/6/11N/AN/AN/ANo Significant Meetings
Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research5/4/11Columbus, OHN/AJames Doroshow (Division of Cancer Treatment and Diagnosis); Michael Caligiuri (The Ohio State University Comprehensive Cancer Center); Eric Rubin (Merck); Ellen Sigal (Friends of Cancer Research)Cancer Drug Development Roundtable at Ohio State